Thinking back, I believe we had personal experience with a sales/marketing rep involved in this prior to the launch. In the 2012~2014 timeframe. And the big message was that it was inhaled.
My thought was - so what? (to keep it clean)
Frankly it seemed stupid, juvenile and gimmicky.
It was not until I read about people’s experience with it on the forums www.tudiabetes.org and forum.fudiabetes.org that I started to understand it has actual real benefits and was not just some gimmick.
Afrezza corrections
I started on Afrezza last night
Afrezza meets low-carb high-fat, a T1D report
On the other hand, I approach this from a T1 perspective and probably don’t understand the T2 perspective. So perhaps the original marketing approach was logical if the target audience was T2 which clearly is substantially larger than the T1 population. (My recollection is that 95% of all diabetics are T2?)